Literature DB >> 26792738

Hepatocyte Factor JMJD5 Regulates Hepatitis B Virus Replication through Interaction with HBx.

Takahisa Kouwaki1, Toru Okamoto1, Ayano Ito1, Yukari Sugiyama1, Kazuo Yamashita2, Tatsuya Suzuki1, Shinji Kusakabe1, Junki Hirano1, Takasuke Fukuhara1, Atsuya Yamashita3, Kazunobu Saito4, Daisuke Okuzaki4, Koichi Watashi5, Masaya Sugiyama6, Sachiyo Yoshio6, Daron M Standley7, Tatsuya Kanto6, Masashi Mizokami6, Kohji Moriishi3, Yoshiharu Matsuura8.   

Abstract

UNLABELLED: Hepatitis B virus (HBV) is a causative agent for chronic liver diseases such as hepatitis, cirrhosis, and hepatocellular carcinoma (HCC). HBx protein encoded by the HBV genome plays crucial roles not only in pathogenesis but also in replication of HBV. Although HBx has been shown to bind to a number of host proteins, the molecular mechanisms by which HBx regulates HBV replication are largely unknown. In this study, we identified jumonji C-domain-containing 5 (JMJD5) as a novel binding partner of HBx interacting in the cytoplasm. DNA microarray analysis revealed that JMJD5-knockout (JMJD5KO) Huh7 cells exhibited a significant reduction in the expression of transcriptional factors involved in hepatocyte differentiation, such as HNF4A, CEBPA, and FOXA3. We found that hydroxylase activity of JMJD5 participates in the regulation of these transcriptional factors. Moreover, JMJD5KO Huh7 cells exhibited a severe reduction in HBV replication, and complementation of HBx expression failed to rescue replication of a mutant HBV deficient in HBx, suggesting that JMJD5 participates in HBV replication through an interaction with HBx. We also found that replacing Gly(135) with Glu in JMJD5 abrogates binding with HBx and replication of HBV. Moreover, the hydroxylase activity of JMJD5 was crucial for HBV replication. Collectively, these results suggest that direct interaction of JMJD5 with HBx facilitates HBV replication through the hydroxylase activity of JMJD5. IMPORTANCE: HBx protein encoded by hepatitis B virus (HBV) plays important roles in pathogenesis and replication of HBV. We identified jumonji C-domain-containing 5 (JMJD5) as a novel binding partner to HBx. JMJD5 was shown to regulate several transcriptional factors to maintain hepatocyte function. Although HBx had been shown to support HBV replication, deficiency of JMJD5 abolished contribution of HBx in HBV replication, suggesting that HBx-mediated HBV replication is largely dependent on JMJD5. We showed that hydroxylase activity of JMJD5 in the C terminus region is crucial for expression of HNF4A and replication of HBV. Furthermore, a mutant JMJD5 with Gly(135) replaced by Glu failed to interact with HBx and to rescue the replication of HBV in JMJD5-knockout cells. Taken together, our data suggest that interaction of JMJD5 with HBx facilitates HBV replication through the hydroxylase activity of JMJD5.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26792738      PMCID: PMC4794694          DOI: 10.1128/JVI.02776-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  78 in total

Review 1.  Regulatory phases of early liver development: paradigms of organogenesis.

Authors:  Kenneth S Zaret
Journal:  Nat Rev Genet       Date:  2002-07       Impact factor: 53.242

2.  The I-TASSER Suite: protein structure and function prediction.

Authors:  Jianyi Yang; Renxiang Yan; Ambrish Roy; Dong Xu; Jonathan Poisson; Yang Zhang
Journal:  Nat Methods       Date:  2015-01       Impact factor: 28.547

3.  X-deficient woodchuck hepatitis virus mutants behave like attenuated viruses and induce protective immunity in vivo.

Authors:  Z Zhang; N Torii; Z Hu; J Jacob; T J Liang
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

4.  Intracellular localization of the hepatitis B virus HBx protein.

Authors:  Frank Henkler; Jonathan Hoare; Naushin Waseem; Robert D Goldin; Michael J McGarvey; Rajen Koshy; Ian A King
Journal:  J Gen Virol       Date:  2001-04       Impact factor: 3.891

5.  Hepatitis B virus HBx protein activation of cyclin A-cyclin-dependent kinase 2 complexes and G1 transit via a Src kinase pathway.

Authors:  M Bouchard; S Giannakopoulos; E H Wang; N Tanese; R J Schneider
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

6.  Structure of factor-inhibiting hypoxia-inducible factor (HIF) reveals mechanism of oxidative modification of HIF-1 alpha.

Authors:  Jonathan M Elkins; Kirsty S Hewitson; Luke A McNeill; Jurgen F Seibel; Imre Schlemminger; Christopher W Pugh; Peter J Ratcliffe; Christopher J Schofield
Journal:  J Biol Chem       Date:  2002-11-21       Impact factor: 5.157

7.  Turnover of hepatitis B virus X protein is regulated by damaged DNA-binding complex.

Authors:  Françoise Bergametti; Delphine Sitterlin; Catherine Transy
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

8.  FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor.

Authors:  David Lando; Daniel J Peet; Jeffrey J Gorman; Dean A Whelan; Murray L Whitelaw; Richard K Bruick
Journal:  Genes Dev       Date:  2002-06-15       Impact factor: 11.361

9.  JMJD5 is a potential oncogene for colon carcinogenesis.

Authors:  Ru Zhang; Qingjun Huang; Yinpeng Li; Yang Song; Yingxue Li
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

10.  Hepatitis B virus efficiently infects non-adherent hepatoma cells via human sodium taurocholate cotransporting polypeptide.

Authors:  Kaori Okuyama-Dobashi; Hirotake Kasai; Tomohisa Tanaka; Atsuya Yamashita; Jun Yasumoto; Wenjia Chen; Toru Okamoto; Shinya Maekawa; Koichi Watashi; Takaji Wakita; Akihide Ryo; Tetsuro Suzuki; Yoshiharu Matsuura; Nobuyuki Enomoto; Kohji Moriishi
Journal:  Sci Rep       Date:  2015-11-23       Impact factor: 4.379

View more
  9 in total

1.  USP15 Participates in Hepatitis C Virus Propagation through Regulation of Viral RNA Translation and Lipid Droplet Formation.

Authors:  Shinji Kusakabe; Tatsuya Suzuki; Yukari Sugiyama; Saori Haga; Kanako Horike; Makoto Tokunaga; Junki Hirano; He Zhang; David Virya Chen; Hanako Ishiga; Yasumasa Komoda; Chikako Ono; Takasuke Fukuhara; Masahiro Yamamoto; Masahito Ikawa; Takashi Satoh; Shizuo Akira; Tomohisa Tanaka; Kohji Moriishi; Moto Fukai; Akinobu Taketomi; Sachiyo Yoshio; Tatsuya Kanto; Tetsuro Suzuki; Toru Okamoto; Yoshiharu Matsuura
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

2.  Peroxiredoxin 1, a Novel HBx-Interacting Protein, Interacts with Exosome Component 5 and Negatively Regulates Hepatitis B Virus (HBV) Propagation through Degradation of HBV RNA.

Authors:  Lin Deng; Xiang Gan; Masahiko Ito; Ming Chen; Hussein H Aly; Chieko Matsui; Takayuki Abe; Koichi Watashi; Takaji Wakita; Tetsuro Suzuki; Toru Okamoto; Yoshiharu Matsuura; Masashi Mizokami; Ikuo Shoji; Hak Hotta
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

3.  Bone morphogenetic protein 4 provides cancer-supportive phenotypes to liver fibroblasts in patients with hepatocellular carcinoma.

Authors:  Yohei Mano; Sachiyo Yoshio; Hirotaka Shoji; Shimagaki Tomonari; Yoshihiko Aoki; Nobuyoshi Aoyanagi; Toru Okamoto; Yoshiharu Matsuura; Yosuke Osawa; Kiminori Kimura; Kyohei Yugawa; Huanlin Wang; Yoshinao Oda; Tomoharu Yoshizumi; Yoshihiko Maehara; Tatsuya Kanto
Journal:  J Gastroenterol       Date:  2019-04-02       Impact factor: 7.527

Review 4.  The current status and future directions of hepatitis B antiviral drug discovery.

Authors:  Liudi Tang; Qiong Zhao; Shuo Wu; Junjun Cheng; Jinhong Chang; Ju-Tao Guo
Journal:  Expert Opin Drug Discov       Date:  2016-11-11       Impact factor: 6.098

5.  Depletion of JMJD5 sensitizes tumor cells to microtubule-destabilizing agents by altering microtubule stability.

Authors:  Junyu Wu; Zhimin He; Da-Liang Wang; Fang-Lin Sun
Journal:  Cell Cycle       Date:  2016-10-07       Impact factor: 4.534

6.  Characterization of miR-122-independent propagation of HCV.

Authors:  Chikako Ono; Takasuke Fukuhara; Daisuke Motooka; Shota Nakamura; Daisuke Okuzaki; Satomi Yamamoto; Tomokazu Tamura; Hiroyuki Mori; Asuka Sato; Kentaro Uemura; Yuzy Fauzyah; Takeshi Kurihara; Takahiro Suda; Akira Nishio; Su Su Hmwe; Toru Okamoto; Tomohide Tatsumi; Tetsuo Takehara; Kazuaki Chayama; Takaji Wakita; Kazuhiko Koike; Yoshiharu Matsuura
Journal:  PLoS Pathog       Date:  2017-05-11       Impact factor: 6.823

7.  RETRACTED: HBV-encoded miR-2 functions as an oncogene by downregulating TRIM35 but upregulating RAN in liver cancer cells.

Authors:  Lili Yao; Yadi Zhou; Zhenhua Sui; Yanling Zhang; Yankun Liu; Hong Xie; Huijie Gao; Hongxia Fan; Yi Zhang; Min Liu; Shengping Li; Hua Tang
Journal:  EBioMedicine       Date:  2019-09-14       Impact factor: 8.143

Review 8.  The JMJD Family Histone Demethylases in Crosstalk Between Inflammation and Cancer.

Authors:  Jia Yang; Yuan Hu; Binjing Zhang; Xiao Liang; Xin Li
Journal:  Front Immunol       Date:  2022-04-26       Impact factor: 8.786

9.  Screening of the HBx transactivation domain interacting proteins and the function of interactor Pin1 in HBV replication.

Authors:  Qiaoxia Zhou; Libo Yan; Baofu Xu; Xue'er Wang; Xuehong Sun; Ning Han; Hong Tang; Feijun Huang
Journal:  Sci Rep       Date:  2021-07-08       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.